Ritholtz Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $17.1M | Sell |
135,292
-3,951
| -3% | -$521K | 0.25% | 49 |
|
|
2026
Q1 | $19.4M | Buy |
139,243
+3,925
| +3% | +$550K | 0.34% | 40 |
|
|
2025
Q4 | $16.6M | Buy |
135,318
+7,865
| +6% | +$956K | 0.3% | 40 |
|
|
2025
Q3 | $14.1M | Buy |
127,453
+12,287
| +11% | +$1.4M | 0.28% | 41 |
|
|
2025
Q2 | $12.8M | Buy |
115,166
+12,726
| +12% | +$1.35M | 0.28% | 41 |
|
|
2025
Q1 | $11.5M | Buy |
102,440
+14,212
| +16% | +$1.47M | 0.34% | 37 |
|
|
2024
Q4 | $8.15M | Buy |
88,228
+39,386
| +81% | +$3.55M | 0.24% | 50 |
|
|
2024
Q3 | $4.09M | Buy |
48,842
+4,125
| +9% | +$315K | 0.12% | 104 |
|
|
2024
Q2 | $3.07M | Sell |
44,717
-15,237
| -25% | -$1.02M | 0.1% | 135 |
|
|
2024
Q1 | $4.39M | Sell |
59,954
-4,088
| -6% | -$314K | 0.15% | 88 |
|
|
2023
Q4 | $5.19M | Buy |
64,042
+1,660
| +3% | +$129K | 0.2% | 60 |
|
|
2023
Q3 | $4.67M | Sell |
62,382
-1,390
| -2% | -$107K | 0.21% | 60 |
|
|
2023
Q2 | $4.91M | Sell |
63,772
-1,713
| -3% | -$137K | 0.22% | 61 |
|
|
2023
Q1 | $5.43M | Sell |
65,485
-2,973
| -4% | -$246K | 0.27% | 49 |
|
|
2022
Q4 | $5.88M | Buy |
68,458
+9,832
| +17% | +$779K | 0.33% | 47 |
|
|
2022
Q3 | $3.62M | Buy |
58,626
+49,837
| +567% | +$3.14M | 0.19% | 69 |
|
|
2022
Q2 | $543K | Buy |
8,789
+2,259
| +35% | +$140K | 0.03% | 302 |
|
|
2022
Q1 | $388K | Sell |
6,530
-3,276
| -33% | -$209K | 0.03% | 360 |
|
|
2021
Q4 | $712K | Buy |
9,806
+1,013
| +12% | +$69.8K | 0.04% | 232 |
|
|
2021
Q3 | $614K | Buy |
8,793
+837
| +11% | +$58.8K | 0.04% | 225 |
|
|
2021
Q2 | $548K | Sell |
7,956
-57
| -0.7% | -$3.81K | 0.04% | 236 |
|
|
2021
Q1 | $518K | Buy |
+8,013
| New | +$517K | 0.04% | 205 |
|
|
2020
Q4 | – | Sell |
-3,857
| Closed | -$244K | – | 415 |
|
|
2020
Q3 | $244K | Sell |
3,857
-200
| -5% | -$13.9K | 0.03% | 239 |
|
|
2020
Q2 | $312K | Buy |
4,057
+1,134
| +39% | +$86.9K | 0.04% | 170 |
|
|
2020
Q1 | $219K | Buy |
+2,923
| New | +$202K | 0.04% | 139 |
|
|
2019
Q3 | – | Sell |
-3,551
| Closed | -$240K | – | 146 |
|
|
2019
Q2 | $240K | Sell |
3,551
-1,075
| -23% | -$70.7K | 0.04% | 112 |
|
|
2019
Q1 | $301K | Sell |
4,626
-340
| -7% | -$22.6K | 0.06% | 101 |
|
|
2018
Q4 | $311K | Sell |
4,966
-509
| -9% | -$35.6K | 0.07% | 92 |
|
|
2018
Q3 | $423K | Sell |
5,475
-1,151
| -17% | -$86.9K | 0.11% | 73 |
|
|
2018
Q2 | $469K | Sell |
6,626
-2,399
| -27% | -$169K | 0.13% | 63 |
|
|
2018
Q1 | $680K | Sell |
9,025
-3,425
| -28% | -$272K | 0.19% | 46 |
|
|
2017
Q4 | $892K | Buy |
+12,450
| New | +$945K | 0.26% | 47 |
|
Other funds holding GILD
Ritholtz Wealth Management's GILD Position: Q2 2026 in Review
Ritholtz Wealth Management reduced its Gilead Sciences (GILD) stake by 2.8% in Q2 2026, selling an estimated $521K and leaving 135,292 shares worth $17.1M. The position accounts for 0.25% of the portfolio, ranked #49.
Ritholtz Wealth Management first reported a position in GILD in Q4 2017 and has held it in 32 quarters since. The position peaked at $19.4M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Ritholtz Wealth Management held 135,292 shares of Gilead Sciences worth $17.1M as of Q2 2026.
- Ritholtz Wealth Management sold 3,951 Gilead Sciences shares in Q2 2026, an estimated $521K.
- Gilead Sciences made up 0.25% of Ritholtz Wealth Management's portfolio in Q2 2026, its #49 holding.
- Ritholtz Wealth Management first reported a position in Gilead Sciences in Q4 2017 and has held it in 32 quarters since.
- Ritholtz Wealth Management's Gilead Sciences position peaked at $19.4M in Q1 2026.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Ritholtz Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.